Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
424studies shown
Showing 201-225 of 424
CompletedNCT00261443

A Study of Aripiprazole (Abilify) in Patients With Bipolar Mania

This study exists to explore whether the medication Aripiprazole could improve care and understanding. Researchers are trying to understand what the medication Aripiprazole could change in day-to-day care and decision-making.

BipolarityOtherOver 18 Years
Countries
Brazil, Bulgaria, Croatia, Czech Republic, France, India, Russian Federation, South Africa, United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Bipolarity
TerminatedNCT02936466

Evaluation of a Serious Game for Patients With Bipolarity Involved in a Psychoeducation Group

This study exists to compare options and see whether psychoeducation, a guided learning and support program, offers something meaningfully different. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can improve sleep, daily rhythms, and longer-term stability.

BipolarityOtherOver 18 Years
Countries
France
Sponsor
University Hospital, Montpellier
Condition
Bipolarity
CompletedNCT02204254

RosaC-RF : Bipolar Radiofrequency vs Doxycycline in Rosacea

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.

BipolarityOtherFrom 18 Years to 70 Years
Countries
France
Sponsor
Centre Hospitalier Universitaire de Nice
Condition
Bipolarity
CompletedNCT03630822

Multicenter, Randomized, Comparative and Prospective Study Evaluating the Impact on the Care Path of an Editorial Program Accompanied by Advance Directives in Psychiatry (DAP) for People Suffering From Schizophrenia, Bipolarity I or Schizoaffective Disorder

This study exists to understand how acceptance and commitment therapy, a talking treatment, holds up over time after the earliest research stage. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherOver 18 Years
Countries
France
Sponsor
Assistance Publique Hopitaux De Marseille
Condition
Schizophrenia
CompletedNCT00280566

Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolarity I (Manic or Mixed)

This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.

BipolarityOtherOver 18 Years
Countries
Chile, France, Germany, Guatemala, China, India, Italy, Mexico, Russian Federation, Spain, Taiwan, United States, Venezuela
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Bipolarity
CompletedNCT03028545

Representations and Strategies for Recovery

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 80 Years
Countries
France
Sponsor
Hôpital le Vinatier
Condition
Schizophrenia
CompletedNCT03249857

Study of Sensorimotor Compatibility Effects in Bipolarity.

This study exists to see whether the medication Sensorimotor can play a useful role in care. Researchers are trying to understand whether the medication Sensorimotor can improve attention, thinking, or day-to-day functioning.

BipolarityOtherFrom 18 Years to 55 Years
Countries
France
Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Condition
Bipolarity
CompletedNCT01973478

Deep Brain Stimulation in Patients With Chronic Treatment Resistant Depression

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.

DepressionOtherFrom 18 Years to 70 Years
Countries
France
Sponsor
Rennes University Hospital
Condition
Depression
CompletedNCT01914393

Pediatric Open-Label Extension Study

This study exists to understand how a medication treatment holds up over time after the earliest research stage. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

SchizophreniaOtherFrom 6 Years to 17 Years
Countries
Bulgaria, Colombia, France, Hungary, Malaysia, Mexico, Philippines, Poland, United States, Romania, Russian Federation, South Korea, Spain, Ukraine
Sponsor
Sumitomo Pharma America, Inc.
Condition
Schizophrenia
TerminatedNCT02472483

Effectiveness of TCC Followed by MBCT and Predictive Factors (Genetic, Clinical and Cognitive) Response

This study exists to explore whether cognitive behavioural therapy, a structured talking treatment, could improve care and understanding. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

BipolarityOtherFrom 18 Years to 65 Years
Countries
France
Sponsor
Centre Hospitalier St Anne
Condition
Bipolarity
TerminatedNCT01674010

Safety and Efficacy Study of ELND005 as an Adjunctive Maintenance Treatment in Bipolarity I

This study exists to understand how the medication ELND005 holds up over time after the earliest research stage. For people living with Bipolarity, that matters because care needs to work in daily life, not just in theory.

BipolarityOtherFrom 18 Years to 65 Years
Countries
Bulgaria, Canada, Czech Republic, France, Poland, Romania, Spain, Turkey, United States
Sponsor
OPKO Health, Inc.
Condition
Bipolarity
CompletedNCT03162380

Occupational Stress and Bipolarity

This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

BipolarityOtherFrom 18 Years to 65 Years
Countries
France
Sponsor
University Hospital, Montpellier
Condition
Bipolarity
CompletedNCT01710709

Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolarity I

This study exists to compare options and see whether the medication OPC-14597 offers something meaningfully different. Researchers are trying to understand whether the medication OPC-14597 can give earlier or clearer feedback during care.

BipolarityOtherFrom 18 Years to 65 Years
Countries
Canada, France, Hungary, Japan, Malaysia, Poland, Romania, South Korea, Taiwan, United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Bipolarity
TerminatedNCT01121536

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolarity I

This study exists to better understand the safety of a therapy or guided support program and how manageable it feels in practice. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.

DepressionOtherFrom 18 Years to 65 Years
Countries
Argentina, Australia, Brazil, Bulgaria, Canada, Croatia, France, Germany, Hungary, Italy, Poland, Serbia, Slovakia, South Africa, Spain, Ukraine, United States
Sponsor
Cephalon
Condition
Depression
CompletedNCT02046369

Lurasidone Pediatric Bipolar Study

This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

BipolarityOtherFrom 10 Years to 17 Years
Countries
Bulgaria, Colombia, France, Hungary, Mexico, Philippines, Poland, United States, South Korea, Ukraine
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity
CompletedNCT01485640

Lurasidone Extended Use Study

This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.

SchizophreniaOther
Countries
Canada, Colombia, Czech Republic, France, India, Lithuania, Romania, Russian Federation, Serbia, Slovakia, South Africa, Ukraine
Sponsor
Sumitomo Pharma America, Inc.
Condition
Schizophrenia
CompletedNCT01358357

Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex

This study exists to understand how the medication Lurasidone holds up over time after the earliest research stage. Researchers are trying to understand how people respond to the medication Lurasidone in practice and what may need to be adjusted.

BipolarityOtherOver 18 Years
Countries
Argentina, Australia, Bulgaria, Chile, Croatia, Czech Republic, France, Hungary, Japan, Poland, Russian Federation, Serbia, Slovakia, United States
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity
CompletedNCT01575561

This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolarity I Who Have Participated in Study D1050296

This study exists to understand how a medication treatment holds up over time after the earliest research stage. Researchers are trying to understand whether a medication treatment can better prevent setbacks and support longer-term stability.

BipolarityOtherOver 18 Years
Countries
Argentina, Bulgaria, Chile, Czech Republic, France, Hungary, Japan, Poland, Russian Federation, Serbia, Slovakia, United States
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity
CompletedNCT02642926

Comparison of the Efficiency of Bipolar Energy Versus Monopolar Energy in Endometrial Ablation in Women Having Menorrhagia

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can better support energy, concentration, and everyday functioning.

BipolarityOtherOver 18 Years
Countries
France
Sponsor
Brugmann University Hospital
Condition
Bipolarity
CompletedNCT01072630

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolarity I

This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand what a therapy or guided support program could change in day-to-day care and decision-making.

DepressionOtherFrom 18 Years to 65 Years
Countries
Argentina, Australia, Bulgaria, Canada, France, Poland, South Africa, Spain, Ukraine, United States
Sponsor
Cephalon
Condition
Depression
CompletedNCT00868959

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

This study exists to explore whether the medication Patients could improve care and understanding. For people living with Depression, that matters because care needs to work in daily life, not just in theory.

DepressionOtherFrom 18 Years to 75 Years
Countries
Canada, Colombia, Czech Republic, France, India, Japan, Lithuania, Peru, Poland, Romania, Russian Federation, Slovakia, South Africa, Ukraine, United States
Sponsor
Sumitomo Pharma America, Inc.
Condition
Depression
TerminatedNCT01809340

The Effect of Minocycline on Relapse After Successful Intravenous Ketamine/Minocycline-induced Symptoms Response in Subjects With Depression

This study exists to compare options and see whether ketamine treatment offers something meaningfully different. Researchers are trying to understand whether ketamine treatment can better prevent setbacks and support longer-term stability.

DepressionOtherFrom 18 Years to 80 Years
Countries
Belgium, France, Netherlands, Spain
Sponsor
Janssen Research & Development, LLC
Condition
Depression
CompletedNCT00490971

A Study to Evaluate the Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo in Delaying the Recurrence of Symptoms in Bipolarity I

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can improve sleep, daily rhythms, and longer-term stability.

BipolarityOtherFrom 18 Years to 65 Years
Countries
Bulgaria, China, Costa Rica, France, Germany, India, Malaysia, Panama, Poland, Romania, Russian Federation, Serbia, South Africa, Turkey, Ukraine, United States
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Bipolarity
France | Clinical Trials | HopeStage Research